Equities

Lippo Karawaci Tbk PT

Lippo Karawaci Tbk PT

Actions
  • Price (EUR)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-59.35%
  • Beta1.5687
Data delayed at least 15 minutes, as of Nov 27 2020 07:06 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

PT Lippo Karawaci Tbk is an Indonesia-based company primarily engaged in property development. It business focuses on four main pillars: properties, healthcare, commercial and asset management. Its properties business comprises the development and sale of residential, commercial, light industrial properties and memorial parks; it is further classified into urban development and large scale integrated development. Under its healthcare business, it operates a number of hospitals in several areas in Indonesia, including Jakarta, Tangerang and Bali, under the brand name Siloam Hospitals. Its commercial segment is further classified into retail malls and hotels; the malls it operates are located in several areas in Indonesia, such as Jakarta, Medan and Surabaya; it operates five-star hotels under the brand name Hotel Aryaduta. Its asset management business comprises First REIT, a healthcare real estate investment trust (REIT), and LMIR Trust, an Indonesian retail-related REIT.

  • Revenue in IDR (TTM)12.48tn
  • Net income in IDR-2.60tn
  • Incorporated1991
  • Employees11.84k
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.